Approxima

medical devices

About

Approxima is a MedTech startup based in Milan, Italy, founded in 2020 as a spin-off from Politecnico di Milano. The company focuses on developing a minimally invasive medical device aimed at treating tricuspid valve regurgitation by reshaping the right ventricle of the heart. This innovative device is designed to be implanted through a percutaneous procedure, guided by medical imaging, and is intended for use on a beating heart. The core product is a percutaneous right ventricle remodeling system that restores tricuspid valve function and addresses right heart dilation. Approxima is currently in the preclinical feasibility phase, conducting in-vivo studies to validate the safety and efficacy of its technology. The company aims to provide a new therapeutic option for high-risk patients with limited surgical alternatives, collaborating with hospitals, cardiologists, and healthcare providers to enhance treatment outcomes. With €7.3 million secured in funding, Approxima is advancing its technology through preclinical validations and pilot clinical trials.

Technologies

Outlook Microsoft Office 365 Mobile Friendly Google Font API WordPress.org

Keywords

medical equipment manufacturing medical devices ventricular reshaping heart failure treatment medical device heart valve therapy percutaneous valve repair medical device funding medical equipment and supplies manufacturing biomedical financing rounds ventricle reshaping implantation procedure percutaneous heart valve minimally invasive treatment minimally invasive device in-vivo data annulus reshaping percutaneous tricuspid valve repair medical device development cardiovascular intervention healthcare technology percutaneous implantation structural heart disease cardiology research collaboration healthcare equipment & supplies device safety top innovation awards tr treatment technology medtech industry events strategic ip protection

Location

Milan, Lombardy, Italy, 20139

Related Companies

Companies in the same industry